Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | TGM2 | P21980 | 1/20 | 0.59 |
| ▸ | IMPDH2 | P12268 | 6/20 | 0.56 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.56 |
| ▸ | KRAS | P01116 | 8/20 | 0.55 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.54 |
| ▸ | HINT1 | P49773 | 1/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.52 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.52 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6027526 | 1.00 | NT5E (0.61) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL7571229 | 0.92 | NT5E (0.60) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL5061620 | 0.92 | NT5E (0.60) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL1235770 | 0.89 | NT5E (0.61) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL180928 | 0.89 | NT5E (0.61) | NT5ETGM2IMPDH2FUT5KRAS | |
| Guanosine SCHEMBL1421810 | 0.89 | TGM2 (0.55) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL8669732 | 0.88 | NT5E (0.59) | NT5ETGM2IMPDH2FUT5KRAS | |
| L-Fucose SCHEMBL18992533 | 0.87 | TGM2 (0.67) | NT5ETGM2IMPDH2FUT5KRAS | |
| L-Fucose SCHEMBL20607674 | 0.87 | TGM2 (0.67) | NT5ETGM2IMPDH2FUT5KRAS | |
| SCHEMBL1269745 | 0.86 | NT5E (0.61) | NT5ETGM2IMPDH2FUT5KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240309413-A1 | GENETICALLY ENGINEERED BACTERIA AND METHODS FOR PREPARING A FUCOSYLATED OLIGOSACCHARIDE USING THE SAME | SYNAURA BIOTECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2024-09-19 | — | — | US | claimed |
| EP-4344436-A1 | GENETICALLY ENGINEERED BACTERIA AND METHODS FOR PREPARING A FUCOSYLATED OLIGOSACCHARIDE USING THE SAME | SYNAURA BIOTECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2024-04-03 | — | — | EP | claimed |
| WO-2023098299-A1 | GENETICALLY ENGINEERED BACTERIA AND METHODS FOR PREPARING A FUCOSYLATED OLIGOSACCHARIDE USING THE SAME | SYNAURA BIOTECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2023-06-08 | — | — | WO | claimed |
| US-8435763-B2 | from cultures of microorganisms in the presence of enzymes; used for immunotherapy, preventing bacterial or viral infections and treating cardiovascular disorders | KYOWA HAKKO BIO CO., LTD. (JP) | 2013-05-07 | — | — | US | claimed |
| US-20050019874-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-01-27 | — | — | US | claimed |
| US-20040058418-A1 | Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-03-25 | — | — | US | claimed |
| EP-1275714-A1 | ALPHA 1,2-FUCOSYLTRANSFERASE AND PROCESS FOR PRODUCING FUCOSE-CONTAINING COMPLEX CARBOHYDRATE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-15 | — | — | EP | claimed |
| EP-1243647-A1 | MODIFIED ALPHA-1,2-FUCOSYLTRANSFERASE GENE AND PROCESS FOR PRODUCING ALPHA-1,2-FUCOSYLTRANSFERASE AND FUCOSE-CONTAINING SUGAR CHAIN | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-09-25 | — | — | EP | claimed |
| US-20020064836-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-05-30 | — | — | US | claimed |
| US-20020025560-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-02-28 | — | — | US | claimed |
| EP-0870841-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-10-14 | — | — | EP | claimed |
| US-5618705-A | REACTING DISACCHARIDE COMPRISING LAMINARIBOSE, GENTIOBIOSE, AND MALTOSE WITH GALACTOSE IN THE PRESENCE OF LACTALBUMIN | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY MECHANICAL COLLEGE (US) | 1997-04-08 | — | — | US | claimed |
| US-20240309413-A1 | GENETICALLY ENGINEERED BACTERIA AND METHODS FOR PREPARING A FUCOSYLATED OLIGOSACCHARIDE USING THE SAME | SYNAURA BIOTECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2024-09-19 | — | — | US | disclosed |
| US-20240124911-A1 | ENZYMATIC METHOD FOR PREPARATION OF GDP-FUCOSE | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2024-04-18 | — | — | US | disclosed |
| EP-4344436-A1 | GENETICALLY ENGINEERED BACTERIA AND METHODS FOR PREPARING A FUCOSYLATED OLIGOSACCHARIDE USING THE SAME | SYNAURA BIOTECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2024-04-03 | — | — | EP | disclosed |
| WO-2024025402-A1 | GENETICALLY ENGINEERED MICROORGANISM FOR PRODUCING 3-FUCOSYLLACTOSE AND METHOD USING SAME | 주식회사 진켐 | 2024-02-01 | — | — | WO | disclosed |
| WO-1999065712-A2 | GLYCOSULFOPEPTIDES AND METHODS OF SYNTHESIS AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5714587-A | DIGLUCO-SIALYL LEWIS-X HAVING ULTIMATE GLUCOSE RESIDUE BOUND TO PROTEIN OR GLYCOPROTEIN | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY (US) | 1998-02-03 | — | — | US | disclosed |
| US-5618705-A | REACTING DISACCHARIDE COMPRISING LAMINARIBOSE, GENTIOBIOSE, AND MALTOSE WITH GALACTOSE IN THE PRESENCE OF LACTALBUMIN | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY MECHANICAL COLLEGE (US) | 1997-04-08 | — | — | US | disclosed |
| US-5426178-A | Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1995-06-20 | — | — | US | disclosed |